Patient characteristics of the 135 female patients with RA. Mean (SD) for continuous variables; percentage for counts
| Characteristics | Value |
|---|---|
| *The denominator varies from 135 as some values were missing. | |
| VAS, visual analogue scale; HAQ, Health Assessment Questionnaire; DAS, disease activity score; ESR, erythrocyte sedimentation rate; DMARDs, disease modifying antirheumatic drugs; DXR, digital hand x ray radiogrammetry; DXA, dual x ray absorptiometry. | |
| Demographic variables | |
| Age (years) | 60.8 (5.8) |
| Body mass index (kg/cm2) | 25.7 (4.8) |
| Current smoker | 32.8 |
| Menopause | 91.1 |
| Menopause age (years) | 46.7 (6.2) |
| Disease variables | |
| Disease duration (years) | 17.3 (10.7) |
| Rheumatoid factor positive | 60.7 |
| Investigator global assessment score (VAS 0–100 mm) | 32.9 (17.8) |
| HAQ (score 0–3) | 1.47 (0.70) |
| Pain (VAS 0–100 mm) | 40.1 (23.0) |
| Swollen joint count (28 joints) | 8.0 (4.7) |
| Tender joint count (28 joints) | 8.5 (6.6) |
| DAS28 | 4.9 (1.2) |
| Mean ESR past 12 months (mm/1st h) | 25.0 (17.6) |
| Joint damage variables | |
| Deformed joint count (18 joints) | 6.6 (5.4) |
| Total hand Larsen score (0–120) | 37.4 (28.5) |
| Treatment | |
| Current use of DMARDs | 70.4 |
| Current use of antiresorptive drugs | 40.7 |
| Prednisolone | |
| Current use | 37.3 |
| Cumulative dose past 12 months (g) | 1.65 (1.82) |
| Bone mineral density (g/cm2) | |
| DXR hand | 0.448 (0.083) |
| DXA femoral neck | 0.843 (0.153) |
| DXA spine L2–4 | 1.134 (0.221) |
| Fractures | |
| Vertebral deformity ⩾ grade 1 | 12.6 |
| Non-vertebral fractures | 13.4 |